Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Not stated	2024-11-21		NCT06587789

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Zhoushan Hospital of Wenzhou Medical University	2
First People's Hospital of Hangzhou	58
Jinhua Central Hospital	29
Ningbo Medical Center Lihuili Hospital	61
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Sir Run Run Shaw Hospital	117
Taizhou Hospital	28
The Affiliated People's Hospital of Ningbo University	21
The First Affiliated Hospital of Bengbu Medical University	47
The First Affiliated Hospital of Zhejiang Chinese Medical University	30
Women's Hospital School Of Medicine Zhejiang University	60
Zhejiang University	194

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Second Affiliated Hospital Of Zhejiang University School of Medicine	Hangzhou	China	12